---
document_datetime: 2023-09-21 18:20:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/aranesp-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: aranesp-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.4793332
conversion_datetime: 2025-12-28 03:47:00.010752
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## PROCEDURAL STEPS TAKEN AFTER GRANTING THE MARKETING AUTHORISATION

For procedures finalised after 1 September 2003 please refer to module 8B.

- -On 13 July 2001, the EMEA issued a notification (I/01) for the following type I variation: extension of the shelf-life of the active substance.
- -On 13 July 2001, the EMEA issued a notification (I/02) for the following type I variation: extension of the shelf-life of the finished product. The European Commission adopted a Decision on 8 October 2001.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                                                                         | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|-----------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Additional indication                                                                                                                         | II/03                | II                       | 28.05.02                            | 22.08.02                                 |
| Change in the name of a manufacturer of the medicinal product                                                                                 | I/04                 | I                        | 11.04.02                            | 16.05.02                                 |
| Change in test procedure of active substance                                                                                                  | I/05                 | I                        | 11.04.02                            | 16.05.02                                 |
| Change in test procedure for starting material/intermediate used in manufacturing of active substance                                         | I/06                 | I                        | 11.04.02                            | 16.05.02                                 |
| Change in test procedure of active substance                                                                                                  | I/07                 | I                        | 29.05.02                            | 31.05.02                                 |
| Change in manufacture of active substance                                                                                                     | I/08                 | I                        | 27.06.02                            | 30.07.02                                 |
| Minor change of manufacturing process                                                                                                         | I/09                 | I                        | 27.06.02                            | 10.07.02                                 |
| Batch size of active substance                                                                                                                | I/10                 | I                        | 27.06.02                            | 10.07.02                                 |
| Change in test procedure of medicinal product                                                                                                 | I/11                 | I                        | 21.06.02                            | 03.07.02                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                                                              | II/13                | II                       | 21.11.02                            | 27.02.03                                 |
| Extension of Indication                                                                                                                       | II/15                | II                       | 22.05.03                            | 11.08.03                                 |
| Change in the batch size of finished product                                                                                                  | I/16                 | I                        | 19.03.03                            | 02.04.03                                 |
| Change in or addition of manufacturing site(s) for part or all of the manufacturing process                                                   | I/17                 | I                        | 10.04.03                            | 23.04.03                                 |
| Change in specification of starting material/intermediate used in manuf. of the active substance                                              | I/18                 | I                        | 03.04.03                            | 08.04.03                                 |
| Update of or change(s) to the pharmaceutical documentation and Change(s) to the test method(s) and/or specifications for the finished product | II/19                | II                       | 24.07.03                            | 28.07.03                                 |